Omarol Tablet 25 mg contains Omarigliptin, a modern oral antidiabetic medication from the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is designed to help manage type 2 diabetes mellitus by improving the body’s natural blood sugar regulation mechanisms. Omarigliptin works by inhibiting the enzyme DPP-4, which results in increased levels of incretin hormones such as GLP-1 and GIP. These hormones enhance glucose-dependent insulin secretion and decrease glucagon release, thereby reducing blood glucose levels both after meals and during fasting.
Omarol 25 mg provides enhanced glycemic control for patients requiring stronger intervention. Its once-weekly dosing offers convenience, improves patient adherence, and reduces the need for multiple daily medications.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Omarol Tablet 25 mg is indicated for:
Type 2 diabetes mellitus: For adults who require improved glycemic control when diet, exercise, or other oral antidiabetic agents are insufficient.
Adjunct therapy: Can be used alongside metformin, sulfonylureas, or insulin to optimize blood sugar management.
Fasting and postprandial glucose control: Helps lower blood sugar levels throughout the day.
It is not recommended for type 1 diabetes or diabetic ketoacidosis.
Once-weekly dosing: Provides convenience and enhances adherence compared to daily medications.
Effective glycemic control: Reduces both fasting and postprandial blood glucose levels.
Supports natural insulin response: Stimulates insulin secretion only when blood sugar is elevated, reducing hypoglycemia risk when used alone.
Suppresses glucagon release: Prevents excessive glucose production by the liver.
Well-tolerated: Exhibits a favorable safety profile with minimal side effects.
Omarol 25 mg is suitable for patients needing stronger, consistent blood sugar control while maintaining convenience and adherence.
The recommended dose is 25 mg once weekly, preferably on the same day each week.
Take the tablet orally with a glass of water, with or without food.
Regular monitoring of blood glucose and HbA1c is advised to evaluate treatment effectiveness.
Continue lifestyle measures including a balanced diet, exercise, and weight management for optimal results.
Dose adjustments may be required in patients with moderate or severe kidney impairment; consult a healthcare provider.
Not indicated for patients with type 1 diabetes or diabetic ketoacidosis.
Use caution in patients with renal impairment or other chronic conditions.
Monitor for signs of hypoglycemia if combined with insulin or sulfonylureas.
Inform your physician of all medications being taken to avoid potential drug interactions.
Pregnancy and breastfeeding use should be considered only under medical supervision.
Omarol Tablet 25 mg is generally well tolerated. Common side effects may include:
Nasopharyngitis or mild respiratory infections
Headache
Nausea, diarrhea, or mild gastrointestinal discomfort
Rare hypoglycemia when used with insulin or sulfonylureas
Serious but rare effects may include pancreatitis or allergic reactions. Seek immediate medical attention if severe symptoms occur.
Store below 25°C in a cool, dry place.
Protect from moisture, heat, and direct sunlight.
Keep out of reach of children.
Do not use after the expiration date printed on the packaging.
Omarol Tablet 25 mg (Omarigliptin) is an effective, once-weekly oral therapy for adults with type 2 diabetes. It improves glycemic control, supports insulin secretion, suppresses glucagon production, and provides a convenient dosing schedule for better long-term adherence and diabetes management.
Login Or Registerto submit your questions to seller
No none asked to seller yet